Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
The British Journal of Diabetes & Vascular Disease
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Hendra, T. J
Right arrow Search for Related Content
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Reviews

Review: Diabetes and insulin therapy in older people

Timothy J Hendra

Department of Geriatric Medicine, Brearley Wing, Northern General Hospital, Herries Road, Sheffield, S5 7AU, UK,Tim, Hendra{at}sth.nhs.uk

Concerns about hypoglycaemia, plus lack of evidence of benefit, contributed to underutilisation of insulin for older people with type 2 diabetes in the past. Following the UKPDS it is clear that many elderly patients treated with diet and oral antidiabetic agents will develop beta-cell failure and will be at risk of worsening glycaemic control with reduced well-being unless insulin is considered. Following diabetes diagnosis, the mainstay of treatment will be dietary control and exercise together with management of cardiovascular risk factors. When glycaemic control deteriorates oral agents will be needed. However, whereas in the past insulin was seen as a last resort for older type 2 patients there is support for considering its early use in selected older people with preserved cognitive function and poor glycaemic control, as well as for frail older people with weight loss and poor quality of life. The regimens of choice may include a combination of basal insulin with oral agents or twice-daily combinations of premixed short and intermediate acting insulin. The development of insulin analogues with their associated reduced risk of hypoglycaemia may also herald a new era of insulin treatment for older people.

Key Words: older people • early use of insulin • quality of life.

References

  • Hendra TJ, Sinclair AJ Improving the care of elderly diabetic patients: the final report of the St Vincent Joint Task Force for diabetes. Age Ageing 1997;26:3-6.[Abstract/Free Full Text]
  • Ford ES, Giles WH, Dietz WH Prevalence of the metabolic syndrome among US adults. Findings from the Third National Health and Nutritional Examination Study. JAMA 2002;287:356-9.[Abstract/Free Full Text]
  • Sinclair AJ, Turnbull CJ, Croxson SCM. Document of care for older people with diabetes. Postgrad Med J 1996;72:334-8.[Free Full Text]
  • Sinclair AJ, Turnbull CJ, Croxson SCM. Document of diabetes care for residential and nursing homes. Postgrad Med J 1997;73:611-12.[Free Full Text]
  • UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-53.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Ohkubo Y., Kishikawa H., Araki E. et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract 1995;28:103-17.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Gaede P., Vedel P., Larsen N. et al. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 2003; 348:383-93.[Abstract/Free Full Text]
  • European Diabetes Working Party For Older People 2000-2003. Clinical Guidelines for Type 2 Diabetes Mellitus. Available from: www.eugms.org
  • Wright A., Burden AC, Paisey RB et al. Sulphonylurea inadequacy: efficacy of addition of insulin over 6 years in patients with type 2 diabetes in the UK Prospective Diabetes Study (UKPDS 57). Diabetes Care 2002;25: 330-6.[Abstract/Free Full Text]
  • Riddle MC Timely initiation of basal insulin Am J Med 2004;116(suppl 3A):3S-9S.
  • 1. Schwartz S., Sievers R., Strange P. et al. Insulin 70/30 Mix plus metformin versus triple oral therapy in the treatment of type 2 diabetes after failure of two oral drugs: efficacy, safety, and cost analysis Diabetes Care 2003;26:2238-43.[Abstract/Free Full Text]
  • Qureshi KN, Hodkinson HM Evaluation of a ten-question mental test in the institutionalised elderly. Age Ageing 1974;3:152-7.[Abstract/Free Full Text]
  • Folstein MF, Folstein SE, McHugh PR `Mini-mental state`: a practical method for grading the cognitive state of patients for the clinician. J Psychiatry Res 1975;12:189-98.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Collins C., Wade DT, Davies S., Horne V. The Barthel Index: a reliability study. Int Disabil Stud 1988;10:61-3.[Medline] [Order article via Infotrieve]
  • Herrmann C. International experiences with the Hospital Anxiety and Depression Scale - a review of validation data and clinical results. J Psychosomatic Research 1987;42:17-42.[CrossRef]
  • Pop Bogatean M., Hancu N. People with type 2 diabetes facing the reality of starting insulin therapy: factors involved in psychological insulin resistance. Pract Diab Int 2004;21:247-52.[CrossRef]
  • Riddle MC, Rosenstock J., Gerich MJ The Treat To Target Trial. Randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients. Diabetes Care 2003;26:3080-6.[Abstract/Free Full Text]
  • Taylor R., Davies R., Fox C. et al. Appropriate insulin regimens for type 2 diabetes. Diabetes Care 2000;23:1612-18.[Abstract/Free Full Text]
  • Yki-Jarvinen H., Ryysy L., Nikkila K. et al. Comparison of bedtime insulin regimens in patients with type 2 diabetes mellitus. Ann Int Med 1999; 130:389-96.[Abstract/Free Full Text]
  • Reza M., Taylor C., Towse K. et al. Insulin improves well-being for selected elderly type 2 diabetic subjects. Diabetes Res Clin Pract 2002;55:201-07.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Hendra TJ, Taylor CD A randomized trial of insulin on well being and carer strain, in elderly type 2 diabetic subjects. J Diabetes Compl 2004; 18:148-54.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Watson GS, Craft S. Modulation of memory by insulin and glucose: neurophysiological observations in Alzheimer's disease. Eur J Pharmacol 2004:490:97-113.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Barnett AH A review of basal insulins. Diabetic Med 2003;20:873-85.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Update on insulin analogues. Drug Ther Bull 2004;42:77-80.[Abstract/Free Full Text]
  • National Institute for Clinical Excellence. Guidance on the use of long-acting insulin analogues for the treatment of diabetes- insulin glargine. December 2002(online). http://nice.org.uk/pdf/53_Insulin_analogues_full_guidance.pdf.
  • Owens DR, Zinman B., Bolli G. Alternative routes of insulin delivery. Diabetic Med 2003;20:886-98.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Hermansen K., Ronnemaa T., Petersen AH, Bellaire S., Adamson U. Intensive therapy with inhaled insulin via the AERx Insulin Diabetes Management System. Diabetes Care 2004;27:162-7.[Abstract/Free Full Text]
  • Taylor C., Towse K., Reza M. et al. Transferring elderly patients to insulin: a prospective study of diabetes nurses' physicians' and patients' perceptions. Pract Diab Int 2002;19:37-9.[CrossRef]
  • Schwartz AV, Hillier TA, Sellmeyer DE et al. Older women with diabetes have a higher risk of falls: a prospective study. Diabetes Care 2002;25: 1749-54.[Abstract/Free Full Text]
  • DeWitt DE, Hirsch IB Outpatient insulin therapy in type 1 and type 2 diabetes mellitus. JAMA 2004;289:2254-64.[Web of Science]

The British Journal of Diabetes & Vascular Disease, Vol. 5, No. 1, 19-23 (2005)
DOI: 10.1177/14746514050050010401


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?



This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Hendra, T. J
Right arrow Search for Related Content
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?